🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer

Neoplasia(2025)10.1016/j.neo.2025.101151Source: DataRank Database

LSD1+8a is an RNA biomarker of neuroendocrine prostate cancer is a research paper published in Neoplasia (2025). On theSindex it has a DataRank of 0.104. It has been cited 1 time.

N/A

0.104DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Cite:

Linked data & code

gen doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 0.38)OA: goldTopics (53)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.104

From this paper's citation signal

Citation Network Contribution

0

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (15)

Rahul Mannan ORCID,Olivia A Swaim ORCID,Eva S. Rodansky,Xiaoming Wang ORCID,Aaron M. Udager ORCID

Live enrichment

PubMed:40088674 PMC:PMC11952868 OpenAlex:https://openalex.org/W4408475511

National Institutes of Health

Grant: PO1CA163227

National Institutes of Health National Cancer Institute

Grant: P50 CA186786-07S1

National Institutes of Health National Cancer Institute

Grant: P30 046592

National Institutes of Health National Cancer Institute

Grant: R01 CA282005

National Institutes of Health National Cancer Institute

Grant: P50 CA097186

National Institutes of Health National Cancer Institute

Grant: R01CA234715

National Institutes of Health National Cancer Institute

Grant: R01 CA251245

US Department of Defense

Grant: W81XWH-20-1-0405

NCI NIH HHS

Grant: P01 CA163227

NCI NIH HHS

Grant: P50 CA186786

NCI NIH HHS

Grant: P30 CA046592

National Institutes of Health

Grant: 1R01CA282005-01A1

Developing New Treatment Strategies for Neuroendocrine Prostate Cancer

National Institutes of Health

Grant: 1R01CA251245-01

Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition

National Institutes of Health

Grant: 6R01CA234715-03

Defining and Targeting Lineage Transition Programs Operative in AR Pathway Independent Prostate Cancer

National Institutes of Health

Grant: 5P50CA097186-13

Clinical Development of Therapeutic Strategies Targeting Damage Responses in the Prostate Tumor Microenvironment

National Institutes of Health

Grant: 5P50CA186786-02

A Precision Medicine Approach to Elucidate Mechanisms of Progression

National Institutes of Health

Grant: 5P30CA046592-23

HEALTH COMMUNICATIONS

National Institutes of Health

Grant: 5P01CA163227-09

Androgen Receptor Action in Castration Resistant Prostate Cancer

University of Michigan

Institute for Prostate Cancer Research

FWCI

0.38

Citation Percentile

0.6%

Citation Trend

2025

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.neo.2025.101151

publisherhttps://doi.org/10.1016/j.neo.2025.101151

publisherhttps://api.elsevier.com/content/article/PII:S1476558625000302?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1476558625000302?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/40088674

Fields of Study

Epigenetics and DNA MethylationGenetic Syndromes and ImprintingProstate Cancer Treatment and ResearchHistone DemethylasesHumansMaleProstatic NeoplasmsBiomarkers, TumorAnimalsCell Line, TumorMiceRNA, MessengerNeuroendocrine Tumors

MeSH Terms

AnimalsHumansMaleProstatic NeoplasmsRNA, MessengerBiomarkers, TumorNeuroendocrine TumorsCell Line, TumorMiceHistone Demethylases

Keywords

Prostate cancerBiomarkerProstateOncologyCancerPCA3RNABiologyMedicineInternal medicineCancer researchGeneGeneticsRna BiomarkerRna In Situ HybridizationNeuroendocrine Prostate CancerLsd1+8aHistone DemethylasesMaleNeoplasms. Tumors. Oncology. Including cancer and carcinogensProstatic NeoplasmsMiceNeuroendocrine TumorsCell Line, TumorBiomarkers, TumorHumansAnimalsRNA, MessengerRC254-282Original Research

Sustainable Development Goals

SDG 0: Good health and well-beingSDG 0: Zero hunger